Table 2 Toxicities during treatment

From: High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

Toxicity

R-MPL (N=69)

R-MP (N=38)

All (N=107)

Leukopenia

 Grade 1

3 (4.4)

7 (19.4)

10 (9.6)

 Grade 2

12 (17.6)

8 (22.2)

20 (19.2)

 Grade 3

32 (47.1)

12 (33.3)

44 (42.3)

 Grade 4

13 (19.1)

2 (5.6)

15 (14.4)

Anaemia

 Grade 1

6 (8.8)

6 (16.7)

12 (11.5)

 Grade 2

31 (45.6)

20 (55.6)

51 (49.0)

 Grade 3

27 (39.7)

6 (16.7)

33 (31.7)

 Grade 4

2 (2.9)

0 (0)

2 (1.9)

Thrombocytopenia

 Grade 1

11 (16.2)

10 (27.8)

21 (20.2)

 Grade 2

11 (16.2)

2 (5.6)

13 (12.5)

 Grade 3

20 (29.4)

0 (0)

20 (19.2)

 Grade 4

9 (13.2)

2 (5.6)

11 (10.6)

Infections

 Grade 1

2 (2.9)

3 (8.3)

5 (4.8)

 Grade 2

12 (17.6)

8 (22.2)

20 (19.2)

 Grade 3

24 (35.3)

8 (22.2)

32 (30.8)

 Grade 4

3 (4.4)

0 (0)

3 (2.9)

Transaminases

 Grade 1

27 (40.3)

7 (19.4)

34 (33.0)

 Grade 2

13 (19.4)

11 (30.6)

24 (23.3)

 Grade 3

14 (20.9)

10 (27.8)

24 (23.3)

 Grade 4

3 (4.5)

0 (0)

3 (2.9)

Hyperbilirubinaemia

 Grade 1

13 (19.1)

5 (13.9)

18 (17.3)

 Grade 2

2 (2.9)

0 (0)

2 (1.9)

 Grade 3

0 (0)

0 (0)

0 (0)

 Grade 4

0 (0)

0 (0)

0 (0)

Renal impairment (serum creatinine)

 Grade 1

20 (29.4)

11 (30.6)

31 (29.8)

 Grade 2

14 (20.6)

7 (19.4)

21 (20.2)

 Grade 3

5 (7.4)

1 (2.8)

6 (5.8)

 Grade 4

0 (0)

0 (0)

0 (0)

Mucositis

 Grade 1

11 (16.4)

4 (11.1)

15 (14.6)

 Grade 2

10 (14.9)

4 (11.1)

14 (13.6)

 Grade 3

5 (7.5)

3 (8.3)

8 (7.8)

 Grade 4

0 (0)

0

0 (0)

Toxic deaths

7 (10.1)

2 (5.3)

9 (8.4)

  1. Abbreviations: R-MP, rituximab, methotrexate and procarbazine; R-MPL, rituximab, methotrexate, procarbazine and lomustine.
  2. Numbers are frequencies (proportions).